Skip to main content
HCPCS J0014 · Level II · Part B drug

J0014: cocaine hydrochloride nasal solution, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J0014

Billing unit
1 MG
Cocaine hcl nasal (goprelto)
ASP payment limit
$1.825
October 2026
Practitioner MUE
none published
CMS publishes no MUE for this code
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J0014 is the Level II code for Cocaine hydrochloride nasal solution (goprelto), 1 mg, billed per 1 MG. The Medicare Part B ASP payment limit for October 2026 is $1.825 per billing unit. Under OPPS it carries status indicator N. With a 1 mg billing unit, a single administration can be hundreds of units; the unit count on the claim must equal the milligrams given, and rounding rules for partial units follow the contractor's guidance. The ASP crosswalk maps 1 NDC to it, sold as Cocaine HCl by LXO US Inc. No current Billing and Coding Article lists J0014, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J0014 at $1.825 per 1 MG for October 2026, derived from manufacturer average sales price plus 6%. Beneficiary coinsurance is 20%.

ASP payment limits for J0014
QuarterPayment limitPerCoinsurance
October 2026$1.8251 MG20%
July 2026n/a1 MG—
CMS note: Added October 2026

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 1 NDC from 1 labeler to J0014. Report the NDC in the claim's drug segment and bill the number of J0014 units that equals the quantity administered divided by 1 MG; the last column gives units per full package.

NDCs that crosswalk to J0014
NDCDrug nameLabelerPackage sizeBilling units / package
70839-0362-04Cocaine HClLXO US Inc.4 × 1160

Medically Unlikely Edits (MUE)

CMS does not publish an MUE for J0014 in the 2026 Q4 tables. Some MUE values are confidential and applied without publication, so unit limits can still deny; document the dose and the units calculation on every claim.

MUE for J0014 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J0014 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J0014 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J0014 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J0014 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J0014 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J0014 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J0014 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J0014

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J0014

What does HCPCS code J0014 describe?

J0014 is defined by CMS as "Cocaine hydrochloride nasal solution (goprelto), 1 mg". Each billing unit represents 1 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J0014 a CPT code?

No. J0014 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as cocaine hydrochloride nasal solution; CPT codes are five-character codes maintained by the AMA. On a Part B claim J0014 reports the drug itself in 1 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J0014 in October 2026?

The ASP-based payment limit is $1.825 per 1 MG, with 20% beneficiary coinsurance. Commercial payers use their own fee schedules.

Which NDCs map to J0014?

The October 2026 ASP crosswalk lists 1 NDC from 1 labeler: Cocaine HCl (LXO US Inc.). For example NDC 70839-0362-04 (package size 4) equals 160 billing units of J0014.

Does J0014 have NCCI bundling edits?

No active practitioner PTP pairs list J0014 as a column-1 or column-2 code in the v323r0 release.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.